MPWT
RLAY icon

MassMutual Private Wealth & Trust’s Relay Therapeutics RLAY Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-28
Closed -$73 – 2475
2025
Q1 		$73 Buy
+28
New +$110 ﹤0.01% 2344

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MassMutual Private Wealth & Trust's RLAY Position: Q2 2025 in Review

MassMutual Private Wealth & Trust sold out of Relay Therapeutics (RLAY) in Q2 2025, closing a stake of 28 shares — an estimated $73 sold.

MassMutual Private Wealth & Trust first reported a position in RLAY in Q1 2025 and held it in 1 quarter. The position peaked at $73 in Q1 2025. 208 funds tracked by Wall St. Rank hold RLAY as of Q2 2025.

  • MassMutual Private Wealth & Trust reported no remaining Relay Therapeutics position as of Q2 2025 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 28 Relay Therapeutics shares in Q2 2025, an estimated $73.
  • MassMutual Private Wealth & Trust first reported a position in Relay Therapeutics in Q1 2025 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Relay Therapeutics position peaked at $73 in Q1 2025.
  • 208 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2025, filed 9 Jul 2025.